Table 1.
Characteristics of the Study Participants
| Features | Viral Load n=2349 Participants | CD4 Count n=2839 Participants | ||||
|---|---|---|---|---|---|---|
| N (%) | Unsuppressed | Missing % | N (%) | < 200 Cells/mL | Missing % | |
| Sex | ||||||
| Male | 838 (35.67) | 45 (5.37) | 0 | 994(35.01) | 367 (36.92) | 0 |
| Female | 1511(64.33) | 110 (7.28) | 1845(64.99) | 801(43.41) | ||
| X2= 3.19 P-value 0.007 | X2= 11.246 P-value =0.001 | |||||
| Marital status | ||||||
| Single | 820(35.91) | 46 (5.61) | 1014(35.01) | 352(34.71) | ||
| Married | 1348(57.39) | 102(7.57) | 0 | 1610(56.71) | 727(45.16) | 5.14 |
| Divorced/ Widowed | 181(7.71) | 7 (3.87) | 215(7.57) | 89(41.40) | ||
| X2= 5.541 P-value = 0.063 | X2= 28.016 P-value =0.000 | |||||
| Functional status | ||||||
| Functional | 2169(92.34) | 2021(93.18) | 0 | 2625(92.46) | 1080(41.14) | 0 |
| Non functional | 180(7.66) | 173(96.11) | 214(7.54) | 88(41.12) | ||
| X2= 28.016 P-value = 0.000 | X2= 0.009 P-value =0.005 | |||||
| Educational status | ||||||
| Cannot read and write | 214(9.11) | 18(8.41) | 259(9.12) | 82(31.66) | ||
| Can read and write | 207(8.81) | 5(2.42) | 0 | 247(8.70) | 104(42.11) | 0 |
| Primary school (1–8) | 265(11.2) | 25(9.43) | 591(20.82) | 254(42.98) | ||
| High school (9–12) | 561(23.88) | 39(6.95) | 645(22.72) | 322(49.92) | ||
| Above secondary | 479(20.39) | 34(7.10) | 784(27.62) | 233(29.72) | ||
| College and above | 623(26.82) | 34(5.46) | 313(11.03) | 173(55.27) | ||
| X2= 15.154 P-value = 0.010 | X2= 99.117 P-value =0.000 | |||||
| WHO stage | ||||||
| Stage 1 | 490(20.86) | 32(6.53) | 591(20.82) | 251(42.47) | ||
| Stage 2 | 1010(43.0) | 64(6.34) | 0.01 | 1174(41.35) | 529(45.06) | 0.13 |
| Stage 3 | 739(31.46) | 56(7.58) | 909(32.02) | 356(39.16) | ||
| Stage 4 | 110(4.68) | 3(2.73) | 165(5.81) | 32(19.39) | ||
| X2= 3.940 P-value = 0.268 | X2= 41.568 P-value =0.000 | |||||
| CD4 at the start of ART | ||||||
| Less than 100 | 479(20.39) | 26(5.43) | 0 | 575(20.25) | 240(41.74) | 0 |
| > =100 | 1870(79.61) | 129(6.90) | 2264(79.75) | 928(40.99) | ||
| X2= 1.337 P-value = 0.247 | X2= 0.106 P-value =0.744 | |||||
| Had opportunistic diseases | ||||||
| Yes | 431(18.35) | 27(6.26) | 0 | 498(17.54) | 220(44.18) | 0 |
| No | 1918(81.65) | 120(6.67) | 2341(82.46) | 948(40.50) | ||
| X2= 0.095 P-value = 0.007 | X2= 2.298 P-value =0.001 | |||||
| Adherence level | ||||||
| Good | 1814(77.22) | 55(3.03) | 2.44 | 2200(77.49) | 903(41.05) | 3.22 |
| Fair | 394(16.77) | 44(11.17) | 479(16.87) | 187(39.04) | ||
| Poor | 141(6.0) | 56(39.72) | 160(5.64) | 70(48.75) | ||
| X2= 301.707 P-value = 0.000 | X2= 4.707 P-value =0.095 | |||||
| Total | 2349 | 155 (6.62) | 2839 | 1168 (41.14) | ||